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AN UPWARD TREND IN DNA P16INK4A METHYLATION PATTERN AND HIGH RISK HPV INFECTION 
ACCORDING TO THE SEVERITY OF THE CERVICAL LESION
Fernanda Nahoum CARESTIATO(1), Larissa Alves AFONSO(1), Natalia MOYSÉS(1), Gutemberg Leão ALMEIDA FILHO(3),  
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SUMMARY
High-risk human papillomavirus (hr-HPV) infection is necessary but not sufficient for cervical cancer development. Recently, 
P16INK4A gene silencing through hypermethylation has been proposed as an important cofactor in cervical carcinogenesis due to 
its tumor suppressor function. We aimed to investigate P16INK4A methylation status in normal and neoplastic epithelia and evaluate 
an association with HPV infection and genotype. This cross-sectional study was performed with 141 cervical samples from patients 
attending Hospital Moncorvo Filho, Rio de Janeiro. HPV detection and genotyping were performed through PCR and P16INK4A 
methylation by nested-methylation specific PCR (MSP). HPV frequency was 62.4% (88/141). The most common HPV were HPV16 
(37%), HPV18 (16.3%) and HPV33/45(15.2%). An upward trend was observed concerning P16INK4A methylation and lesion degree: 
normal epithelia (10.7%), low grade lesions (22.9%), high grade (57.1%) and carcinoma (93.1%) (p < 0.0001). A multivariate analysis 
was performed to evaluate an association between methylation, age, tobacco exposure, HPV infection and genotyping. A correlation 
was found concerning methylation with HPV infection (p < 0.0001), hr-HPV (p = 0.01), HSIL (p < 0.0007) and malignant lesions 
(p < 0.0001). Since viral infection and epigenetic alterations are related to cervical carcinoma, we suggest that P16INK4A methylation 
profile maybe thoroughly investigated as a biomarker to identify patients at risk of cancer.
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INTRODUCTION
Cervical cancer is one of the most common malignancies affecting 
women worldwide, and its occurrence has steadily increased in those of 
young ages. This disease is more prevalent among low socioeconomic 
status populations and is a major health problem in developing countries. 
It is estimated that cervical carcinoma is responsible for 274,000 deaths 
worldwide annually24.
It is well established that infection of high-risk human papillomavirus 
(hr-HPV) is necessary for cervical cancer development; yet it has been 
observed that infection alone is not a sufficient cause. Rather, genetic 
and epigenetic factors have been suggested as contributing mechanisms 
to cervical carcinogenesis20.
Methylation is an epigenetic mechanism of gene silencing that has 
been recognized to play an important role in several human neoplasias. In 
mammalian somatic cells, a methyl group is covalently added to cytosine 
in the context of CpG islands of gene promoters. DNA methylation of 
these CpG-rich promoters silences gene expression by changing the 
accessibility of DNA to transcription factors or by recruiting additional 
silencing-associated proteins2.
A growing number of studies evaluating methylation of host genes 
in cervical tissue have been published8,19. Methylation has already 
been detected in precancerous stages, suggesting that in addition to 
the functional implications of gene inactivation in tumor development, 
these aberrant methylation patterns represent excellent targets for novel 
diagnostic approaches based on sensitive PCR techniques2.
Despite the diverse studies available in the literature, there is still a 
high degree of heterogeneity in methylation frequencies for some genes 
related to cervical cancer development and progression8,9. P16INK4A is 
an important target due to its role in cell cycle19. This tumor suppressor 
gene encodes the p16 protein that is directly involved in inhibiting the 
G1–S transition of the cell cycle. Specifically, p16 inhibits the ability 
of CDK4 and CDK6 to phosphorylate the retinoblastoma (Rb) protein 
and loss of its normal function might lead to uncontrolled cell growth, 
escape from senescence and induction of proliferation20.
It has been speculated that aberrant methylation in women with 
or without HPV infection may help identify subgroups at increased 
risk for histological progression or cancer development. Nevertheless, 
there have been few studies evaluating tumor suppressor methylation in 
different stages of cervical disease22,23. Hence, the aim of this study was 
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to investigate the methylation status ofP16INK4A in the full spectrum 
of cervical lesions as well as in normal epithelia and evaluate a possible 
association of this epigenetic event with HPV infection and genotype, in 
order to verify a possible role for methylation in cancer establishment.
MATERIALS AND METHODS
Study population and study design - This cross-sectional study was 
performed with 141 cervical samples (exfoliated cell and biopsy samples) 
representing the full spectrum of cervical pathology (i.e., samples with 
and without various degrees of Cervical Intraepithelial Neoplasia - CIN 
and Invasive cervical cancer - ICC) as well as in normal healthy epithelia. 
Samples were collected from patients attending Moncorvo Filho Hospital, 
Rio de Janeiro, Brazil between December 2004 and November 2006. 
This research was approved by ethical review boards from the mentioned 
institution. All the subjects filled out a questionnaire based interview 
regarding their age and tobacco exposure. Samples from women who 
were pregnant or infected with HIV were excluded from the study. 
Samples from the endocervix were collected and bisected for standard 
cytopathologic diagnosis (and histopathologic, when available), while 
the other portion was immersed in TRIS-EDTA buffered solution and 
frozen at -20 ºC for subsequent molecular analyses. Cervical specimens 
were evaluated using the Bethesda System and classified as normal 
epithelia, low-grade squamous intraepithelial cells (LSIL), high grade 
squamous intraepithelial cells (HSIL), squamous cells carcinoma (SCC) 
and adenocarcinoma (AC)18.
HPV DNA detection and typing - HPV DNA detection was 
performed with consensus primers MY09/11, which amplify a 
450bpDNA sequence within the L1 region of HPV, were used to detect 
generic HPV DNA. Briefly, amplification was carried out in 50 μL 
reaction mixture (1X PCR buffer, 200 μM dNTPs, 1.5mM MgCl2, 50 
pmol of each primer, 0.25 U unit of Taq polymerase, and 5 μL of sample) 
with 40 cycles of amplification. Each cycle included a denaturation step 
at 94 ºC for one minute, an annealing step at 55 ºC for one minute, and 
a chain elongation step at 72 ºC for one minute using DNA Thermal 
Cycler (Life Technologies). A β-globin primer pair (0.1 pmol each), 
which amplify a 330bp region of the human DNA, was used as internal 
control. Polymerase chain reaction (PCR) products were analyzed on 
1.5% agarose gel with ethidium bromide staining. HPV typing was 
executed by PCR amplification with primers from the E6/E7 gene DNA 
sequences of HPV 6, 11 (low risk for cervical cancer) and 16, 18, 31, 
33, 35, 45 and 58 (high risk for cervical cancer)17. PCR conditions were 
as follow: 94 ºC for five min, followed by 35 cycles of 94 ºC for 30 
seconds, 60 ºC for one minute, and 72 ºC for one minute. No Template 
Controls (NTCs) for background contamination were also included. The 
PCR run was completed after an extension step for ten minutes at 72 ºC.
Bisulfite modification - Bisulfite modification was performed 
according to HERMAN et al.7 with slight protocol modifications. One 
μg of genomic DNA was denatured with NaOH. The bisulfite treatment 
(during which methylated DNA is protected, and unmethylated cytosine 
is converted to uracil) was carried out for 16h at 50 ºC on denatured 
genomic DNA. Samples were then purified using the Wizard DNA Clean-
Up System (Promega®, Madison, WI, USA), treated again with NaOH, 
ethanol-precipitated and resuspended in sterile water.
Nested-methylation specific PCR- MSP-PCR was done according 
to PALMISANO et al.15 with slight modifications. Briefly, first reaction 
was carried out with 5 μL of bisulfite treated DNA using the primers 
did not discriminate between methylated and unmethylated nucleotides. 
Hence, amplicons were subjected to a second PCR step that were 
designed to recognize bisulfite-induced modifications of unmethylated 
cytosines, converted to uracils through PCR, from unmodified cytosines 
of methylated samples, by using two pairs of primers (methylated M and 
unmethylated U). NTC´s were included. Methylation of a specific gene 
was considered to be present if both the specimen and the positive control 
DNA were amplified by M primers after sodium bisulfite modification. 
PCR results were interpreted by two independent reviewers that had no 
access to histology or cytology results.
Statistical analysis - Statistical analysis was performed using S-PLUS 
8.0 (TIBCO Software, USA). Differences were considered statistically 
significant when p < 0.05 (CI: 95%). The frequency of categorical variables 
was described by their absolute values and percentages, whereas numerical 
variables as mean and standard deviation. Chi-square or Fisher’s exact 
tests were used for the comparison of categorical variables. For numerical 
variables, as far as P16INK4A methylation status is concerned, Student`s 
t or Willcoxon rank-sum tests were used. A multivariate analysis using 
logistic regression was performed to evaluate the association between the 
presence of methylation of P16INK4A and other variables such as lesion 
of the uterine cervix, smoking habits, age and HPV infection.
RESULTS
After cytological and histological analysis, studied samples were 
Fig. 1 - Gel A shows a methylated sample (band on p16M), Gel B shows a methylated sample 
with mixed forms (P16U + and p16M +). In both gels, Line 1 presents the ladder 50bp Track-It 
(Lifetech), Line 2 shows positive control for p16 unmethylated, Line 3 shows positive control 
for p16 methylated, Line 4 and 5 show negative controls for both primer pairs. Line 6 and 7 
shows a cervical cancer sample (gel A) and a HSIL sample (Gel B).
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classified as normal, corresponding to 19.8% (28/141) of the cases, 
LSIL (24.8%, 35/141), HSIL (34.8%, 49/141) and invasive cancer 
(20.6%, 29/141). Among cancer cases, 25 were classified as squamous 
cell carcinoma (SCC) and four as adenocarcinoma (AC), according to 
histopathological diagnosis.
The average age of the studied women was 39.1 ± 15.9 (19-85 years 
old). In samples presenting cervical lesions, there was an upward trend 
in the patient’s age according to the severity of the lesions (LSIL: 35.9 
± 13.7; HSIL: 38.6 ± 17.9; Ca: 42.8 ± 12.4, respectively). Nearly 40% 
of the patients were current smokers and the average tobacco exposure 
was 15.3 ± 3.1 cigarettes per day. Women without lesions presented the 
smaller tobacco exposure (11.7 ± 8.0 cigarettes/day) and those with 
LSIL, the highest (19.2 ± 8.2). Patients showing AC were not smokers, 
while those presenting SCC consumed 14.8 ± 6.8 cigarettes/day, average.
Regarding the molecular detection of HPV DNA, 62% (88/141) of the 
studied cases were HPV positive, by using consensual primers MY09/11. 
Patients presenting no cytological alterations had an HPV prevalence of 
7.1% (2/28), while in altered cases with cytologic identifiable lesions 
it was detected in 76.1% (86/113) of the samples. Among them, LSIL 
showed prevalence of 60% (21/35) and according to the severity of the 
lesion, prevalence rates increased to 75.5% (37/49) in HSIL and 96.5% 
(28/29) in carcinoma. A strong statistical association was revealed 
concerning HPV DNA detection and cervical lesion (OR: 41.6(8.6-70.6); 
p < 0.0001, CI: 95%) (Table 1).
HPV genotyping was successful in 96.6% (85/88) of the samples. 
Undetermined HPV were designed as HPV X. High frequency of hr-
HPV was detected, representing 78.4% (69/88) of the studied samples, 
prevailing in samples with altered cytology results (p = 0.03). Infections 
with low risk types were identified in 7.9% (7/88) of the cases, all in 
cytological negative cases. We detected 10.2% (9/88) of the samples 
presenting co-infection with two genotypes (Table 2). Among hr-HPV 
detected, HPV16 was the most prevalent type (37%), followed by HPV18 
(16.3%), HPV33 and HPV45 (15.2% both). Other high risk genotypes 
were found in lower rates such as HPV31 (2.4%) and HPV58 (1.2%). 
HPV35 was not detected in any of the samples included in the study. 
Among low risk types, HPV6 was the most common, being detected in 
13% of the cases, followed by HPV11 that was shown in one case of 
co-infection along with HPV6.
The methylation profile of the P16INK4A gene was determined: 
sixty-six (44.6%) of the cases displayed hypermethylated of P16INK4A 
promoter. Among them, 15.2% (10/66) presented an exclusively 
methylated pattern, while the rest 84.4% (56/66) showed a mixed pattern 
composed by methylated and unmethylated DNA (amplification observed 
for both primers M and U).
The frequency of methylation in samples showing cytological/
histological normal results was 10.7% (3/28). Low and high grade lesions 
displayed methylation 22.9% (8/35) and 57.1% (28/49), respectively. The 
highest frequency was observed in malignant lesions, 93.1% (27/29). 
An upward trend was observed according to the severity of the cervical 
lesions, with a high statistical significance (p < 0.001).
After determining P16INK4A hypermethylation status, an univariate 
analysis were conducted in order to verify a possible association between 
variables such as age, tobacco smoking, smoking dosage (cigarettes per 
day), cytological diagnosis, HPV infection and genotype, summarized 
in Table 1. There was no significant differences regarding the average 
number of cigarettes smoked per day between women who presented 
methylated and unmethylated P16INK4A profile (p = 0.622). Furthermore, 
no significant association was found between active tobacco exposure (p 
= 0.107) or smoke quantitation (p = 0.394) and P16INK4A methylation 
status. Despite a significant statistical difference in the average age of 
women with P16INK4A methylated or unmethylated (p = 0.011), no 
association between age and P16INK4A methylation status was found (p 
= 0.248). Interestingly, a strong statistical significance was found between 
presence of HPV genome, presence of any hr-HPV genotype and with 
altered cytology results and lesions (p < 0.0001) (Table 1).
Table 2
Prevalence of low and high-risk human papillomavirus (HPV) genotypes 
according to histological grading of the lesions
Lesion Low risk HPV 
High risk 
HPV*
Co-
infection HPV X TOTAL
Normal Cells 1 1 - - 2
LSIL 3 16 1a 1 21
HSIL 3 26 6b 2 37
Ca - 26 2c - 28
TOTAL 7 (7.9%) 69 (78.4%) 9 (10.2%) 3 (3.4%) 88
* High risk HPV versus cervical lesions (χ²: p = 0.03); aHPV 6/16, bHPV 6/11, 
6/33, 6/16, 6/18, 16/45, 33/45, cTwo cases of 16/18.
Table 1 
Univariate analysis of independent variables and methylation status of 
P16INK4A among the studied patients
Variable
P16INK4A methylation status
Methylated Unmethylated p value
Age (years)
     < 40 years
     ≥ 40 years
     Age (years)
17
49
43.2 ± 15.3
27
48
36.9 ± 13.4
p = 0.248
p = 0.011 
Active smoking
     YES
     NO
     Cigarettes/day
38
28
15.9 ± 8.8
31
44
14.4 ± 9.4
p = 0.107 
p = 0.622
Cigarettes/day 
     < 20
     ≥ 20 
14
11
2
5
p = 0.394
HPV positive
     YES
     NO
58
8
30
45
p < 0.0001
hr-HPV
     YES
     NO
55
3
22
8
p < 0.0001
Cytology results
     Normal
     Altered
3
63
25
50
p < 0.0001
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To confirm univariate analysis results and avoid confounding, a 
multivariate analysis was performed using logistic regression (Table 3). 
According to our results, no association was found between age, active 
tobacco exposure or smoking quantitation and the presence of P16INK4A 
methylation. On the other hand, a strong statistical significance was 
found between HPV DNA detection/hr-HPV genotypes and methylated 
P16INK4A profile (p < 0.0001 and p = 0.01). Among hr-HPV genotypes, 
the chance of methylation among women with HPV18 infection (p = 
0.02, OR: 10.75 (1.35-25.3)) and HPV16 (p = 0.03, OR: 5.81 (1.14-
29.4)) was higher when compared to other genotypes detected in our 
study (data not shown in the table). Interestingly, no association was 
found between methylation status and low grade lesions (p = 0.05) but we 
found a correlation between high grade and cancer cytology results and 
the presence of methylation (p = 0.005 for HSIL and p < 0.0001 for Ca).
DISCUSSION
In the last decade, it has been shown that DNA methylation patterns 
are profoundly altered in several human neoplasias. In malignant 
cells, while the most part of the genome undergoes global genomic 
hypomethylation, CpG islands within gene promoter regions suffer 
dense hypermethylation. This is the best characterized epigenetic change 
associated with gene transcriptional silencing, thus providing a DNA-
based surrogate marker for expression status10. It has been increasingly 
recognized over the past decade that the CpG islands of a large number 
of genes which are unmethylated in normal tissue are methylated to 
varying degrees in multiple types of human neoplasm, including cervical 
cancer9,21,22.
The most promising hypermethylated genes that could be used as 
biomarkers for cervical cancer have been recently analyzed in a systematic 
review23. A large heterogeneity among results from different studies was 
found regarding the hypermethylation frequency of several genes. In 
addition to these discordances, few published studies have evaluated 
the correlation between P16INK4A hypermethylation in cervical 
lesions along with HPV detection and genotyping14. We investigated 
the frequency of P16INK4A hypermethylation in samples presenting 
all cervical carcinogenesis lesion stages and attempted to correlate this 
phenomenon with HPV infection, genotyping and cytological results.
Our results showed a higher frequency of methylated alleles when 
compared to previous studies, which points out frequencies varying from 
5% to 60% in cervical cancer samples and 3% to 35% in premalignant 
lesions3,8,12,22. It is noteworthy that the majority of studies used cervical 
biopsies and conventional MSP technique to evaluate P16INK4A 
methylation status. In contrast, in the current study we used exfoliated cell 
samples, which are the primary non invasive screening method for detection 
of cervical cancer and precursor lesions, combined with Nested-MSP. The 
feasibility of this combination has been demonstrated previously6.
In our study the methylation mixed pattern (amplification with both 
primers: p16U and p16M) predominated in contrast with NEHLS et al.13 
study, which performed MSP technique with micro-dissected biopsies 
and showed a predominance of simple methylated forms. The percentage 
of mixed methylation pattern decreased after micro-dissection probably 
due to removal of contaminating cells such as normal, stromal cells and 
inflammatory cells.
We believe that these methodological differences might partly 
explain our results, once PALMISANO et al.15 showed that the 
sensitivity of Nested-MSP is five-fold higher than the conventional 
method. Furthermore, these discrepancies may be due to the different 
characteristics of study populations since it is well established that factors 
such as age and smoking habits are also associated with changes in the 
epigenetic profile of an individual25.
Univariate analysis results showed a strong statistical association 
between the presence of cervical lesion and P16INK4A methylation (p 
< 0.0001) and multivariate analysis confirmed this association. However, 
it was statistically significant only for HSIL and Ca cases (p = 0.005 and 
p < 0.0001, respectively) (Table 3). Our results suggest that P16INK4A 
hypermethylation may be a cofactor in cervical carcinogenesis stages, 
contributing to the emergence of premalignant lesions and neoplastic 
transformation of cervical epithelium, which is in agreement with JEONG 
et al.8 and VIRMANI et al.22. We believe that this phenomenon contributes 
to progression of low-grade lesions towards high-grade lesions, which 
are considered the true precursor of cervical cancer. Nevertheless, other 
studies are necessary to confirm our data.
We also had the opportunity to assess the association between 
several variables (age, tobacco exposure, cervical lesion degree, HPV 
infection and genotype) and P16INK4A hypermethylation. No statistical 
association was found regarding smoking nor age with the presence 
of methylated forms of P16INK4A (p = 0.1; p = 0.11, respectively) 
(Table 1). LEA et al.11 found that aberrant methylation of p16 gene is 
strongly correlated with active tobacco exposure in cervical high-grade 
dysplasia and SCC. However, the authors did not evaluate the number 
of cigarettes consumed per day to eliminate possible bias and did not 
perform a multivariate analysis. In our study we were able to evaluate 
this association but no statistical association was found (Table 3).
Table 3
Multivariate analysis of independent variables and methylation status of 
P16INK4A among the studied patients using logistic regression model
Variable
P16INK4A methylation status
Methylated
(n = 66)
Unmethylated
(n = 75)
p value *
 [OR (IC)]
Age (years) 43.2 36.9 p = 0.1 
OR: 1.02 (0.99-1.05)
Tobacco exposure
Cigarettes/day
38
15.9
31
14.4
p = 0.11 
OR: 1.95 (0.84-4.50)
p = 0.1
OR: 1.04 (0.76-2.74)
Presence of HPV 
hr-HPV
66
55
30
22
p < 0.0001
OR: 6.04 (2.25-16.4)
p = 0.01
OR: 5.82 (1.95-19.3)
LSIL
HSIL
Carcinoma 
8
28
27
27
21
2
p = 0.05
OR: 3.82 (0.95-15.4)
p = 0.005
OR: 10.23 (2.73-38.3)
p < 0.0001
OR: 52.08 (10.57-72.69)
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In our study, we report a highly significant statistical association 
between the presence of hr-HPV infection and detection of methylated 
P16INK4A forms (p < 0.001) as showed by SPATHIS et al.19. In fact, 
diverse studies have already correlated viral exposure to epigenetic 
alterations and human cancer such as Hepatitis B Virus and Hepatitis C 
Virus with hepatocellular carcinoma16,26.
WU et al.25 described a relevant HPV16 and 18 infection association 
within activation of p16INK4A gene through promoter hypermethylation 
in lung cancer samples obtained from non-smoking patients. The authors 
proposed that HPV infection might promote hypermethylation. It is well 
known that E7 gene of HPV16 and 18 is involved in Rb inactivation and 
release of histone deacetylase (HDAC) from E2F-Rb-HDAC complex, 
enhancing P16INK4A hypermethylation through chromatin remodeling 
by HDAC5. Such DNA methylomes were now confirmed by in vivo 
studies (FERNANDEZ et al.4).
Besides, a study performed by BURGERS et al.1 found that HPV 
oncoproteins have the ability to modulate the enzymatic machinery 
involved in gene methylation in vitro and in vivo. The authors described 
that HPV16 E7 protein binds to and stimulates the activity of the 
DNMT1 enzyme, which are directly involved in DNA methylation. 
These discoveries suggested that the virus could indirectly promote the 
silencing of its own genes, evading host immune defenses to favor the 
establishment of a persistent infection. However, uncontrolled activation 
of these enzymes could eventually lead to important cellular genes 
silencing, such as gene P16INK4A.
New approaches for the recognition and treatment of high-risk 
patients are needed to improve survival and avoid over-treatment of 
low-risk patients. Indeed, identification of viral and host factors that 
contribute to the delineation of women at the highest risk of HPV infection 
persistence and progression will lead to selected candidate markers that 
can potentially be used for diagnostic or prognostic purposes.
Despite their being interesting, our results should be interpreted 
with caution since we cannot state whether hr-HPV infection triggers 
P16INK4A methylation and larger studies are needed to confirm our 
findings. Such studies are of great importance since hypermethylation 
counteracts p16 expression disturbing cell cycle control and thus may 
represent a risk factor for cervical premalignant and malignant lesion 
development.
Methylome studies, along with our results suggest these epigenetic 
events to be biomarkers that can be used as complementary tools to 
define risk of cancer establishment along with hr-HPV detection. The 
clinical validation and utility of candidate markers must, therefore, be 
thoroughly investigated.
RESUMO
Padrão de metilação do gene P16INK4A e de infecções por HPV 
de alto risco acompanham a evolução de lesões cervicais 
É reconhecido que infecções por papilomavírus humanos de alto risco 
(HPV) são causa necessária, mas não suficiente para o desenvolvimento 
do câncer cervical. Recentemente, estudos de silenciamento gênico 
apontaram que a hipermetilação do gene p16INK4A é importante co-
fator para a carcinogênese cervical, eliminando a função supressora de 
tumor da proteína p16 em lesões malignas. Entretanto poucos estudos 
avaliaram a relação da metilação com a progressão da doença. Nosso 
objetivo foi investigar o padrão de metilação do gene P16INK4A em 
diferentes graus de lesão cervical e sua associação com a infecção por 
diferentes tipos de HPV. Nosso estudo de corte transversal avaliou 
141 amostras cervicais de pacientes atendidas no Hospital Moncorvo 
Filho, Rio de Janeiro. A detecção e tipagem do HPV foi realizada pela 
técnica de reação em cadeia da polimerase (PCR), e a metilação do gene 
P16INK4A pela PCR-metilação específica em formato nested (MSP). A 
frequência de HPV foi de 62,4% (88/141). O tipo mais prevalente foi 
o HPV16 (37%), seguido pelo HPV18 (16,3%) e HPV33/45 (15,2%). 
Curva ascendente foi observada quanto ao padrão de metilação do gene 
P16INK4A e o grau da lesão: a metilação foi identificada em somente 
10,7% das amostras de epitélio normal, em 22,9% das lesões de baixo 
grau, em 57,1% das lesões de alto grau e em 93,1% dos carcinomas 
(p < 0,0001). Foram feitas análises univariada e multivariada a fim de 
correlacionar metilação, idade, exposição ao tabaco, infecção e genótipo 
de HPV. Foi encontrada correlação da metilação com a infecção pelo 
HPV (p < 0,0001), genótipos de alto risco (p = 0,01), lesões de alto grau 
(p < 0,0007) e câncer (p < 0,0001). Uma vez que infecções pelo HPV 
e alterações epigenéticas mostraram forte associação estatística com o 
carcinoma cervical, sugerimos que estes padrões de metilação possam 
ser avaliados como potenciais biomarcadores, combinados à detecção 
dos HPV oncogênicos para identificação de pacientes em risco de câncer. 
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